In silico identification of potent PPAR-γ agonists from traditional chinese medicine: A bioactivity prediction, virtual screening, and molecular dynamics study

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Chen, Kuan Chung ^a   Chen, Calvin Yu Chian ^b,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; CARBOXYL GROUP; INDOLE; LIGAND; N METHYLTRYPTOPHAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; SAUSSUREAMINE A; SAUSSUREAMINE B; SAUSSUREAMINE C; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CHINESE MEDICINE; COMPUTER MODEL; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG SCREENING; GLUCOSE HOMEOSTASIS; HUMAN; LIPID METABOLISM; MOLECULAR DYNAMICS; PREDICTION; VIRTUAL REALITY;

EID: 84902158832     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/192452     Document Type: Article

References (54)

1. Evans R. M., Barish G. D., Wang Y.-X., PPARs and the complex journey to obesity. Nature Medicine 2004 10 4 355 361 2-s2.0-1942518840 10.1038/nm1025
2. Rikimaru K., Wakabayashi T., Abe H., Imoto H., Maekawa T., Ujikawa O., Murase K., Matsuo T., Matsumoto M., Nomura C., Tsuge H., Arimura N., Kawakami K., Sakamoto J., Funami M., Mol C. D., Snell G. P., Bragstad K. A., Sang B.-C., Dougan D. R., Tanaka T., Katayama N., Horiguchi Y., Momose Y., A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) γ agonists: design and synthesis of benzylpyrazole acylsulfonamides. Bioorganic and Medicinal Chemistry 2012 20 2 714 733 2-s2.0-84855797701 10.1016/j.bmc.2011.12.008
3. Feige J. N., Gelman L., Michalik L., Desvergne B., Wahli W., From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progress in Lipid Research 2006 45 2 120 159 2-s2.0-32644460092 10.1016/j.plipres.2005.12.002
4. Poulsen L., Siersbaek M., Mandrup S., PPARs: fatty acid sensors controlling metabolism. Seminars in Cell & Developmental Biology 2012 23 6 631 639
5. Ahmadian M., Suh J. M., Hah N., PPARgamma signaling and metabolism: the good, the bad and the future. Nature Medicine 2013 19 5 557 566 10.1038/nm.3159
6. Bugge A., Mandrup S., Molecular mechanisms and genome-wide aspects of PPAR subtype specific transactivation. PPAR Research 2010 2010 12 2-s2.0-77957933413 10.1155/2010/169506 169506
7. Miller A. R., Today's challenges and tomorrow's opportunities: ligands to peroxisome proliferator-activated receptors as therapies for type 2 diabetes and the metabolic syndrome. Drug Development Research 2006 67 7 574 578 2-s2.0-33845232611 10.1002/ddr.20125
8. Lehmann J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Willson T. M., Kliewer S. A., An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ). The Journal of Biological Chemistry 1995 270 22 12953 12956 2-s2.0-0029016829 10.1074/jbc.270.22.12953
9. Kubota N., Terauchi Y., Miki H., Tamemoto H., Yamauchi T., Komeda K., Satoh S., Nakano R., Ishii C., Sugiyama T., Kazuhiro E., Tsubamoto Y., Okuno A., Murakami K., Sekihara H., Hasegawa G., Naito M., Toyoshima Y., Tanaka S., Shiota K., Kitamura T., Fujita T., Ezaki O., Aizawa S., Nagai R., Tobe K., Kimura S., Kadowaki T., PPAR γ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Molecular Cell 1999 4 4 597 609 2-s2.0-0033212964 10.1016/S1097-2765(00)80210-5
10. Forman B. M., Chen J., Evans R. M., The peroxisome proliferator-activated receptors: ligands and activators. Annals of the New York Academy of Sciences 1996 804 266 275
11. Cheatham W. W., Peroxisome proliferator-activated receptor translational research and clinical experience. The American Journal of Clinical Nutrition 2010 91 1 262S 266S 2-s2.0-74049087919 10.3945/ajcn.2009.28449D
12. Sharma A. M., Staels B., Review: peroxisome proliferator-activated receptor γ and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. The Journal of Clinical Endocrinology and Metabolism 2007 92 2 386 395 2-s2.0-33847006604 10.1210/jc.2006-1268
13. Li Y.-T., Li L., Chen J., Hu T.-C., Huang J., Guo Y.-W., Jiang H.-L., Shen X., 7-chloroarctinone-b as a new selective PPAR γ antagonist potently blocks adipocyte differentiation. Acta Pharmacologica Sinica 2009 30 9 1351 1358 2-s2.0-70249146489 10.1038/aps.2009.113
14. Wu J.-S., Cheung W.-M., Tsai Y.-S., Chen Y.-T., Fong W.-H., Tsai H.-D., Chen Y.-C., Liou J.-Y., Shyue S.-K., Chen J.-J., Chen Y. E., Maeda N., Wu K. K., Lin T.-N., Ligand-activated peroxisome proliferator-activated receptor- γ protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 ε upregulation. Circulation 2009 119 8 1124 1134 2-s2.0-62649096776 10.1161/CIRCULATIONAHA.108.812537
15. Jao C.-L., Huang S.-L., Hsu K.-C., Angiotensin I-converting enzyme inhibitory peptides: inhibition mode, bioavailability, and antihypertensive effects. BioMedicine 2012 2 4 130 136
16. Lin M., Tsai S., Wang F., Liu F.-H., Syu J.-N., Tang F.-Y., Leptin induces cell invasion and the upregulation of matrilysin in human colon cancer cells. BioMedicine 2013 3 4 174 180
17. Su K.-P., Inflammation in psychopathology of depression: clinical, biological, and therapeutic implications. BioMedicine 2012 2 2 68 74
18. Leissring M. A., Malito E., Hedouin S., Reinstatler L., Sahara T., Abdul-Hay S. O., Choudhry S., Maharvi G. M., Fauq A. H., Huzarska M., May P. S., Choi S., Logan T. P., Turk B. E., Cantley L. C., Manolopoulou M., Tang W.-J., Stein R. L., Cuny G. D., Selkoe D. J., Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin. PLoS ONE 2010 5 5 e10504 2-s2.0-77956274306 10.1371/journal.pone.0010504
19. Jiang Y., Li X., Yang W., PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Molecular Cell 2014 53 1 75 87 10.1016/j.molcel.2013.11.001
20. Chou I. C., Lin W.-D., Wang C.-H., Association analysis between Tourette's syndrome and two dopamine genes (DAT1, DBH) in Taiwanese children. BioMedicine 2013 3 2 88 91
21. Yamamoto T., Hung W.-C., Takano T., Nishiyama A., Genetic nature and virulence of community-associated methicillin-resistant Staphylococcus aureus. BioMedicine 2013 3 1 2 18
22. Wang C.-H., Lin W.-D., Bau D.-T., Chou I.-C., Tsai C.-H., Tsai F.-J., Appearance of acanthosis nigricans may precede obesity: an involvement of the insulin/IGF receptor signaling pathway. BioMedicine 2013 3 2 82 87
23. Chen W., Wang Z., Jiang C., Ding Y., PP2A-mediated anticancer therapy. Gastroenterology Research and Practice 2013 2013 10 10.1155/2013/675429 675429
24. Chang Y.-M., Velmurugan B. K., Kuo W.-W., Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells. BioMedicine 2013 3 4 148 152 10.1016/j.biomed.2013.05.001
25. 2+ store-depleted rat insulinoma RINm5F cells. BioMedicine 2013 3 3 130 139 10.1016/j.biomed.2012.11.003
26. Mahamuni S. P., Khose R. D., Menaa F., Badole S. L., Therapeutic approaches to drug targets in hyperlipidemia. BioMedicine 2012 2 4 137 146
27. Chen K. C., Chang S. S., Tsai F. J., Chen C. Y., Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine? Journal of Biomolecular Structure & Dynamics 2013 31 11 1219 1235
28. Chen K.-C., Sun M.-F., Yang S.-C., Chang S.-S., Chen H.-Y., Tsai F.-J., Chen C. Y.-C., Investigation into potent inflammation inhibitors from traditional Chinese medicine. Chemical Biology & Drug Design 2011 78 4 679 688 2-s2.0-80052619174 10.1111/j.1747-0285.2011.01202.x
29. Chen K. C., Jian Y. R., Sun M. F., Chang T. T., Lee C. C., Chen C. Y., Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine. Journal of Biomolecular Structure & Dynamics 2013 31 11 1207 1218 10.1080/07391102.2012.726191
30. Hsu S.-C., Lin J.-H., Weng S.-W., Crude extract of Rheum palmatum inhibits migration and invasion of U-2 OS human osteosarcoma cells by suppression of matrix metalloproteinase-2 and -9. BioMedicine 2013 3 3 120 129 10.1016/j.biomed.2013.04.008
31. Chen C.-Y., Chen C. Y.-C., Insights into designing the dual-targeted HER2/HSP90 inhibitors. Journal of Molecular Graphics & Modelling 2010 29 1 21 31 2-s2.0-77955772552 10.1016/j.jmgm.2010.04.002
32. Yang S.-C., Chang S.-S., Chen H.-Y., Chen C. Y.-C., Identification of potent EGFR inhibitors from TCM Database@Taiwan. PLoS Computational Biology 2011 7 10 2-s2.0-80055077153 10.1371/journal.pcbi.1002189 e1002189
33. Tsou Y. A., Chen K. C., Lin H. C., Chang S. S., Chen C. Y. C., Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study. PLoS ONE 2012 7 11
34. Tsou Y. A., Chen K. C., Chang S. S., Wen Y. R., Chen C. Y., A possible strategy against head and neck cancer: in silico investigation of three-in-one inhibitors. Journal of Biomolecular Structure & Dynamics 2013 31 12 1358 1369
35. Tou W. I., Chang S. S., Lee C. C., Chen C. Y. C., Drug design for neuropathic pain regulation from traditional Chinese medicine. Scientific Reports 2013 3, article 844 10.1038/srep00844
36. Chen K.-C., Chang K.-W., Chen H.-Y., Chen C. Y.-C., Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once? Molecular BioSystems 2011 7 9 2711 2719 2-s2.0-80051760684 10.1039/c1mb05164d
37. Chang T.-T., Chen K.-C., Chang K.-W., Chen H.-Y., Tsai F.-J., Sun M.-F., Chen C. Y.-C., In silico pharmacology suggests ginger extracts may reduce stroke risks. Molecular BioSystems 2011 7 9 2702 2710 2-s2.0-80051767195 10.1039/c1mb05228d
38. Huang H. J., Jian Y. R., Chen C. Y., Traditional Chinese medicine application in HIV: an in silico study. Journal of Biomolecular Structure & Dynamics 2014 32 1 1 12
39. Chang S.-S., Huang H.-J., Chen C. Y.-C., Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine. PLoS Computational Biology 2011 7 12 2-s2.0-84855282742 10.1371/journal.pcbi.1002315 e1002315
40. Chen K. C., Chang S. S., Huang H. J., Lin T. L., Wu Y. J., Chen C. Y., Three-in-one agonists for PPAR-alpha, PPAR-gamma, and PPAR-delta from traditional Chinese medicine. Journal of Biomolecular Structure & Dynamics 2012 30 6 662 683
41. Chen C. Y.-C., TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PLoS ONE 2011 6 1 2-s2.0-79251561193 10.1371/journal.pone.0015939 e15939
42. Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 2001 46 1-3 3 26 2-s2.0-0035289779 10.1016/S0169-409X(00)00129-0
43. Li Y., Wang Z., Furukawa N., Escaron P., Weiszmann J., Lee G., Lindstrom M., Liu J., Liu X., Xu H., Plotnikova O., Prasad V., Walker N., Learned R. M., Chen J.-L., T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor γ binding properties. The Journal of Biological Chemistry 2008 283 14 9168 9176 2-s2.0-44049104049 10.1074/jbc.M800104200
44. Rogers D., Hopfinger A. J., Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships. Journal of Chemical Information and Computer Sciences 1994 34 4 854 866 2-s2.0-0028467707
45. Chang C., Lin C.-J., LIBSVM: a library for support vector machines. ACM Transactions on Intelligent Systems and Technology 2011 2 3 1 27
46. Venkatachalam C. M., Jiang X., Oldfield T., Waldman M., LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. Journal of Molecular Graphics & Modelling 2003 21 4 289 307 2-s2.0-0037212102 10.1016/S1093-3263(02)00164-X
47. Brooks B. R., Bruccoleri R. E., Olafson B. D., States D. J., Swaminathan S., Karplus M., CHARMM: a program for macromolecular energy minimization and dynamics calculations. Journal of Computational Chemistry 1983 4 187 217
48. Wallace A. C., Laskowski R. A., Thornton J. M., LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Engineering 1995 8 2 127 134 2-s2.0-0028922586
49. Hess B., Kutzner C., van der Spoel D., Lindahl E., GRGMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation 2008 4 3 435 447 2-s2.0-46249092554 10.1021/ct700301q
50. Zoete V., Cuendet M. A., Grosdidier A., Michielin O., SwissParam: a fast force field generation tool for small organic molecules. Journal of Computational Chemistry 2011 32 11 2359 2368 2-s2.0-79958841703 10.1002/jcc.21816
51. Fletcher R., Optimization 1969 New York, NY, USA Academic Press
52. Bonchev D., Information Theoretic Indices for Characterization of Chemical Structures 1983 Research Studies Press
53. Kier L. B., Hall L. H., Molecular Connectivity in Chemistry and Drug Research 1976 New York, NY, USA Academic Press
54. Balaban A. T., Highly discriminating distance-based topological index. Chemical Physics Letters 1982 89 5 399 404 2-s2.0-9444296174